Fenfluramine Enrolling by Invitation Phase 3 Trials for Dravet Syndrome Treatment

IndicationsStatusPurposePhase
Enrolling by InvitationTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT02823145An Open-Label Extension Trial to Assess the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride HCl) Oral Solution in Children and Young Adults With Dravet Syndrome
NCT03299842A Study to Assess the Usability of the Embrace Seizure Detection Watch in Children and Young Adults With Dravet Syndrome